Trackers› Clinical trials› Primary Myelofibrosis

Clinical trial register · France

Primary Myelofibrosis Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC

9722

Studies in scope

all four open statuses

6047

Recruiting now

open to new participants

1031

Lead sponsors

across recruiting studies

Top sites

Paris 1 Amiens 1 Angers 1 Lille 1 Lyon 1

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site location

All 8 locations

Target enrolment

Primary Myelofibrosis trials in France

Status

Study

Lead sponsor

Phase

Enrol

Sites in France

Start

Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

NCT06479135Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis, Primary Myelofibrosis

DrugsNavtemadlin·Jakavi·Ruxolitinib

Kartos Therapeutics, Inc.

Phase 3

600

Paris, Amiens, Angers, Lille, Lyon, Nantes, Nice, Nîmes

2024-06-03

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/condition/primary-myelofibrosis

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies listing the condition Primary Myelofibrosis that also match the filters currently applied.

How many Primary Myelofibrosis trials are recruiting in France?

1 of the 1 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Primary Myelofibrosis), 1 studies
Phase	Studies	Recruiting	Share
Phase 3	1	1	100%

Most active sponsors

Lead sponsors with the most studies (Primary Myelofibrosis)
Lead sponsor	Studies	Recruiting
Kartos Therapeutics, Inc.	1	1

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.